On 9 September 2021, Factor Therapeutics Limited (the Company or FTT), lodged a replacement prospectus (Replacement Prospectus) with the Australian Securities and Investments Commission in connection with its listing on the Australian Securities Exchange via an initial public offering of new fully paid ordinary shares (Shares) to be issued in the name of Dominion Minerals Limited (ASX:DLM).

If you would like to apply for Shares in the Priority Offer you need to read the Replacement Prospectus in full and complete the online application form available on the Offer website found at https://events.miraqle.com/FTT-IPO